Literature DB >> 10588555

Spinal anesthesia with 0.5% S(-)-bupivacaine for elective lower limb surgery.

D Burke1, S Kennedy, J Bannister.   

Abstract

BACKGROUND AND OBJECTIVES: This study examines the clinical effects of the subarachnoid administration of levobupivacaine, the S(-)-enantiomer of racemic bupivacaine.
METHODS: An open, noncomparative study was performed on 20 patients undergoing elective lower limb surgery. Three milliliters of a plain solution of 0.5% S(-)-bupivacaine ( 15 mg) was administered via the L2 or L3 interspace with the patient in the sitting position. Following injection, the patients were immediately placed supine. Spread of sensory analgesia, degree of motor block, and hemodynamic parameters were recorded.
RESULTS: Satisfactory surgical anesthesia was achieved in 18 patients. The median time to onset of analgesia was 2 minutes (ranging 2-10 minutes) and the median duration of analgesia was 388 minutes (range, 295-478 minutes). This group of patients achieved complete motor block, with a median onset time of 5 minutes (2-10 minutes) and duration of 266 minutes (range, 170-415 minutes). Sensory block height was inadequate for surgery in 2 patients, who received supplemental anesthesia.
CONCLUSIONS: The results suggest that S(-)-bupivacaine can provide satisfactory surgical anesthesia, but the spread of the plain solution is unpredictable.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588555     DOI: 10.1016/s1098-7339(99)90042-1

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  10 in total

Review 1.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 2.  Levobupivacaine: a review of its pharmacology and use as a local anaesthetic.

Authors:  R H Foster; A Markham
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Pain Input Impairs Recovery after Spinal Cord Injury: Treatment with Lidocaine.

Authors:  Joel D Turtle; Misty M Strain; Miriam Aceves; Yung-Jen Huang; Joshua A Reynolds; Michelle A Hook; James W Grau
Journal:  J Neurotrauma       Date:  2016-12-02       Impact factor: 5.269

4.  A comparison of spinal anesthesia characteristics following intrathecal bupivacaine or levobupivacaine in lumbar disc surgery.

Authors:  Ayça Sultan Şahin; Gürkan Türker; Ahmet Bekar; Hülya Bilgin; Gülsen Korfalı
Journal:  Eur Spine J       Date:  2013-11-09       Impact factor: 3.134

5.  The comparative study of epidural levobupivacaine and bupivacaine in major abdominal surgeries.

Authors:  Ali Uzuner; Kemal Tolga Saracoglu; Ayten Saracoglu; Ozcan Erdemli
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

6.  Influence of positioning on plain levobupivacaine spinal anesthesia in cesarean section.

Authors:  Fabio Gori; Francesco Corradetti; Vittorio Cerotto; Vito Aldo Peduto
Journal:  Anesthesiol Res Pract       Date:  2010-05-24

7.  Hemodynamic impact of isobaric levobupivacaine versus hyperbaric bupivacaine for subarachnoid anesthesia in patients aged 65 and older undergoing hip surgery.

Authors:  Rosa Herrera; Jose De Andrés; Luis Estañ; Francisco J Morales Olivas; Inocencia Martínez-Mir; Thorsten Steinfeldt
Journal:  BMC Anesthesiol       Date:  2014-10-24       Impact factor: 2.217

8.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

9.  Comparison of intrathecal levobupivacaine combined with sufentanil, fentanyl, or placebo for elective caesarean section: a prospective, randomized, double-blind, controlled study.

Authors:  Nesrin Bozdogan Ozyilkan; Aysu Kocum; Mesut Sener; Esra Caliskan; Ebru Tarim; Pinar Ergenoglu; Anis Aribogan
Journal:  Curr Ther Res Clin Exp       Date:  2013-12

10.  Clinical profile of levobupivacaine in regional anesthesia: A systematic review.

Authors:  Sukhminder Jit Singh Bajwa; Jasleen Kaur
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.